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In this issue of Developmental Cell, Rane et al. report a cellular pathway to link PrPSc, via ER stress and the
activation of a preemptive quality control process, to neurodegeneration in a PrP-dependent manner. This
pathway puts together several pieces in the puzzle of the relationship between PrPSc and brain damage
and may in part explain the mechanism of prion neurodegeneration.
Transmissible spongiform encephalopa-
thies (TSEs), also known as prion disor-
ders, are a group of fatal and infectious
neurodegenerative diseases. The central
event in TSEs is the misfolding, aggrega-
tion, and brain accumulation of the prion
protein. The misfolded form of the prion
protein (termed PrPSc) is not only the typ-
ical pathological feature of the disease
and a possible triggering event in the
pathogenesis, but it is also the major
(and perhaps the sole) component of the
infectious agent.
Despite the impressive knowledge
about the characteristics of the TSE
infectious agent and its mechanism of
replication, the association of PrPSc and
neurodegeneration and the molecular
pathways leading to cerebral damage
are for the most part unknown. The most
accepted idea is that misfolding and ag-
gregation result in a gain of toxic activity
of PrPSc. The initial model, that PrPSc
aggregates cause direct neurotoxicity,
seemed reasonable considering that
other, more prevalent neurodegenerative
disorders such as Alzheimer’s and Parkin-
son’s diseases are also characterized
by cerebral accumulation of misfolded
protein aggregates (Soto, 2003). Although
purified PrPSc was shown to be neuro-
toxic at very lowconcentrations, a number
of observations argue that this model is an
oversimplification. Indeed, a discrepancy
between the amount of PrPSc aggregates
and the extent of brain damage and dis-
ease has been reported in various exper-
iments (Piccardo et al., 2007, and refer-
ences therein). Furthermore, in studies
with postnatal PrP knockout animals, it
was observed that depletion of PrPC in
mice with established prion infection
reversed early spongiform degeneration
and prevented neuronal loss and progres-
sion to clinical disease (Mallucci et al.,
2003). Importantly, this occurred despite
the accumulation of extraneuronal PrPSc
to levels similar to terminally ill, wild-type
infected animals (Mallucci et al., 2003).
These data suggested that PrPSc
might not be directly responsible for
neurodegeneration and that expression
of PrPC plays an essential role in this
process.
At least two models can explain
these discrepancies (Figure 1): first, the
neurotoxic species may not be mature
aggregated PrPSc, but a cell-associated
and transient oligomeric intermediate
that requires PrPC expression for its con-
tinuous formation (Figure 1A). This model
is appealing, as a similar paradigm
change is occurring in other disorders
associated with misfolding and aggrega-
tion of proteins. Indeed, studies from
Alzheimer’s, Parkinson’s, and other
misfolding disorders have provided
compelling evidence that small (difficult
to detect) oligomers appear to be the
culprit in causing brain damage
(Caughey and Lansbury, 2003). A second
possibility is that PrPSc interacts with
cells through its binding to PrPC,
triggering a signal transduction path-
way that leads to neuronal damage
(Figure 1B). This hypothesis is supported
by the fact that the normal and patholog-
ical forms of PrP bind tightly in the
context of the cell membrane. Further-
more, PrPC-antibody cross-linking ex-
periments have shown the induction of
a cellular signaling pathway, resulting in
neuronal dysfunction (Solforosi et al.,
2004).
In the current issue of Developmental
Cell, Rane and colleagues report an inter-
esting third possibility (Figure 1C) (Rane
et al., 2008). The authors’ hypothesis,
supported by a set of elegant experi-
ments, is that TSE neurodegeneration
might be dependent on the chronic endo-
plasmic reticulum (ER) stress produced
by PrPSc accumulation, which in turn
lead to persistent activation of a ‘‘preemp-
tive’’ quality control system (pQC) that
aborts the ER translocation of PrP, allow-
ing its proteasome-mediated degradation
in the cytosol. This pathway constitutes
a defense mechanism to prevent nascent
protein entry into the ER lumen during
conditions of compromised ER function.
However, under chronic ER stress condi-
tions, the proteasome may become over-
whelmed, resulting in PrP accumulation in
the cytosol. It has been shown in cell
culture experiments that cytosolic accu-
mulation of PrP (cyPrP) produced by
pharmacological inhibition of the protea-
some lead to PrPSc-like formation and
neurotoxicity (Ma et al., 2002). Further-
more, artificial expression of PrP in the
cytosol in transgenic animals expressing
a construct lacking ER-targeting and
GPI-anchoring signals cause severe neu-
rodegeneration (Ma et al., 2002). To test
their hypothesis, Rane and coworkers
created transgenic mice with a greater
or lower proportion of PrP routed to the
pQC pathway, independent of PrPSc
accumulation or ER stress. The results
showed that even a modest increase in
PrP routing to pQC degradation for
prolonged periods of time caused
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neurodegenerative changes (clinical and
histological) that partially resemble those
observed in prion diseases (Rane et al.,
2008). These results provide a plausible
model for PrPSc cell-type selective neu-
rotoxicity in a PrPC-dependent pathway,
implicating ER stress and changes of
protein trafficking. The findings also sug-
gest that pharmacological agents able to
reduce ER stress or the pQC pathway
might have potential for the treatment of
prion diseases. However, both mild ER
stress and the pQC pathway can be ben-
eficial. Indeed, it has been shown that the
first response to ER stress is the launch-
ing of the unfolded protein response
(UPR), resulting in the upregulation of
various molecular chaperones and de-
creased general protein synthesis (Hetz
and Soto, 2006). Also, as Rane and co-
workers pointed out, the ability of PrP
to be delivered to the pQC pathway ap-
pears to have evolved for avoiding its
misfolding under ER stress conditions.
Therefore, it seems that the pathogenic
mechanisms in prion diseases may be
the result of overwhelming a normally
beneficial quality control defense mech-
anism.
Although the authors’ hypothesis is
appealing and the role of ER stress in
prion diseases is well documented
(Hetz and Soto, 2006), the relevance or
even the existence of cyPrP is highly
controversial (Fioriti et al., 2005). Further-
more, the transgenic mice with increased
PrP translocation to the pQC pathway
reported in this study show a relatively
mild neurodegenerative phenotype that
recapitulates only a subset of TSE pa-
thology (Rane et al., 2008). Thus, as the
authors acknowledge, it is likely that
other cellular pathways are also contrib-
uting to prion-induced neurodegenera-
tion. Finally, an intriguing question not
yet explored is whether altered PrP
translocation leading to neurodegenera-
tion might be implicated in other brain
diseases in which ER stress occurs. In-
deed, extensive reports have shown
sustained ER stress in several neurode-
generative diseases associated to the
accumulation of misfolded aggregated
proteins (Lindholm et al., 2006). It could
be interesting to assess whether under
these PrPSc-unrelated ER stress condi-
tions, nascent PrP is also routed to the
pQC pathway, leading to proteasomal
dysfunction and brain degeneration. It
would also be interesting to study
whether other proteins besides PrP are
abnormally translocated and delivered
to the pQC pathway during ER stress
and their potential contribution to brain
degeneration in TSEs and other neuro-
degenerative diseases.
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Figure 1. Role of PrPSc and Mechanism of Neurodegeneration
Although PrPSc is certainly associated to the pathogenesis of TSEs, its role is neurodegeneration is con-
troversial. Several observations suggest that PrPSc levels do not correlate with the extent of brain damage
and that the natively folded PrPC is required for neurodegeneration. Three non-mutually exclusive models
can be proposed to explain the discrepancies and the implication of PrPC.
(A) First, the infectious and neurotoxic PrP species might not be the same. Indeed, it is possible that an
undetectable misfolded intermediate might be responsible for neurotoxicity in a way similar to that pro-
posed for other neurodegenerative diseases. The transient nature of these intermediates determines
that its presence depends on the permanent synthesis of new PrPC.
(B) PrPC located in the cell surface may act as a receptor for PrPSc, triggering a signal transduction path-
way leading to neurodegeneration.
(C) As proposed by Rane and colleagues in this issue (Rane et al., 2008), induction of ER stress by PrPSc
may lead to translocation of nascent PrPC molecules to the cytosol for proteasomal degradation as a way
to alleviate the damaged ER (pQC pathway). However, this mechanism of defense turns negative under
chronic ER stress conditions, overwhelming the proteasome and leading to the cytosolic accumulation
of potentially toxic PrP molecules.
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Reporting in Molecular Cell, Sheridan et al. (2008) and Breckenridge et al. (2008) show that mitochondrial
fragmentation is not required to induce cell death. Meanwhile, Yamaguchi et al. show that proapoptotic
Bcl-2 family members promote cytochrome c mobilization through Opa1-mediated cristae remodeling.
Therefore, the connection between mitochondrial structure and apoptosis is more complex than previously
imagined.
Mitochondria are known to forma filamen-
tous network that extends throughout the
cell. The dynamics of this network are reg-
ulated by the proteins Drp1 and Fis1,
which control the fission of the outer mito-
chondrial membrane, and Opa1, which
is required for the fusion of the inner
membrane. Following an apoptotic signal,
Drp1 translocates from the cytosol to the
mitochondria and triggers mitochondrial
fission prior to caspase activation. At the
mitochondrial fission sites, Drp1 colocal-
izes with the proapoptotic Bcl-2 family
members Bax and Bak, which are respon-
sible for mitochondrial outer membrane
permeabilization (MOMP). Inhibiting the
fission process by downregulating Fis1
or Drp1 activity has been purported to
alter cytochrome c release and delay
apoptosis, suggesting that Drp1-induced
mitochondrial fission plays a role in
MOMP and the release of cytochrome c
(Suen et al., 2008). Now Sheridan et al.
(2008) report that, in mammalian cells,
mitochondrial fission is not required for
MOMP and apoptosis.
Overexpression of fission proteins is
known to cause cell death that can be
inhibited by antiapoptotic Bcl-2 family
members without affecting the transition
from the tubular to punctate mitochon-
drial morphology. This suggested that
fragmentation and apoptosis could be un-
coupled (Arnoult, 2006). Sheridan et al.
(2008) have comprehensively investi-
gated this issue using fragmentation in-
duced by Bcl-xL or Mcl-1—antiapoptotic
BH3-domain-containing proteins of the
Bcl-2 family. Using fluorescent recovery
after photobleaching to monitor mito-
chondrial fragmentation, they showed
that mitochondria were disconnected
following Bak or Bax overexpression. Al-
though Bcl-xL or Mcl-1 could inhibit the
release of apoptotic markers cytochrome
c and Smac/DIABLO within these Bax/
Bak-overexpressing cells, the fragmenta-
tion persisted, thus indicating that MOMP
and mitochondrial fission were separable
events. Interestingly, they also showed
that Bcl-xL on its own appeared to disrupt
mitochondrial morphology and that both
proapoptotic and antiapoptotic Bcl-2
family members—in addition to affecting
mitochondrial fragmentation—may have
different targets within the machinery
that governs the movement of mitochon-
dria in cells.
Experiments performed by Brecken-
ridge et al. (2008) in C. elegans led to
a similar conclusion. The fission and
fusion machinery is broadly conserved in
C. elegans and even though MOMP has
not been observed, mitochondrial frag-
mentation occurs in cells expressing the
BH3-only proapoptotic protein EGL-1,
which are destined to undergo develop-
mental cell death (Jagasia et al., 2005).
However, the role of the fusion and fission
genes in apoptosis remained to be char-
acterized. Breckenridge et al. showed
that mutants in mitochondrial fusion
(fzo-1, eat-3) and fission (Drp1) genes
were embryonic lethal, yet mutants in the
known orthologs of hFis1 (fis1 and fis2)
were viable. Studying the mitochondria
in the early embryo showed that the fusion
mutants gave rise to a fragmented mito-
chondrial network, whereas the Drp1mu-
tant displayed highly fused mitochondria.
Yet developmental cell death in these
mutants was found to occur normally.
This contrasts with a recent paper (Jaga-
sia et al., 2005) that showed that an over-
expressed Drp1 mutant (Drp1-K40A)
increased the number of surviving cells
duringdevelopment.However, in amutant
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